Brain Stimulation for Speech Motor Learning
Trial Summary
Will I have to stop taking my current medications?
Yes, you will need to stop taking antipsychotic, antidepressant, and antianxiety drugs to participate in this trial.
What data supports the effectiveness of the treatment Adaptation, cTBS, Continuous Theta-Burst Stimulation, cTBS, Theta-Burst Transcranial Magnetic Stimulation for speech motor learning?
Research shows that continuous theta burst stimulation (cTBS) can influence brain activity related to motor learning, which might help in speech motor learning. Studies have found that cTBS can affect motor cortex excitability and motor learning, suggesting it could be useful for improving speech-related motor skills.12345
Is theta-burst transcranial magnetic stimulation (TBS) safe for humans?
Theta-burst transcranial magnetic stimulation (TBS) is generally considered safe for humans, with most adverse events being mild and occurring in about 5% of people. However, there is a small risk of seizures, so it should be used with caution, especially since it is a relatively new technique.24678
How is the treatment cTBS different from other treatments for speech motor learning?
Continuous theta-burst stimulation (cTBS) is unique because it uses magnetic pulses to temporarily reduce brain activity in specific areas, which can help with learning speech motor skills by targeting the brain's motor cortex. Unlike other treatments, cTBS can produce longer-lasting effects with a brief session, making it a novel approach for enhancing speech motor learning.13469
What is the purpose of this trial?
The proposed studies focus on memory for speech movements and sounds and its relation to learning. Continuous theta-burst transcranial magnetic stimulation (cTBS) will be used to suppress activity in a region of pre-frontal cortex associated with somatic and auditory working memory (Brodmann area 46v) to test its involvement in learning.
Research Team
David Ostry
Principal Investigator
Haskins Laboratories
Eligibility Criteria
This trial is for right-handed adults with no known physical or neurological abnormalities. It's not suitable for those with metal in their body, claustrophobia, on antipsychotic/antidepressant/antianxiety drugs, pregnant women, anyone with heart clips or implants, a history of concussion or epilepsy.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo auditory and somatosensory working memory tests followed by adaptation to altered auditory feedback. cTBS is used to disrupt neural activity in Brodmann area 46v.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Adaptation
- cTBS
cTBS is already approved in United States for the following indications:
- Major Depressive Disorder (using iTBS protocol)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator